PetIQ, Inc. - (PETQ) News
Filter PETQ News Items
PETQ News Results
|Loading, please wait...|
PETQ News Highlights
- 500 - Internal server error
- Over the past 19 days, the trend for PETQ's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- PHG and QGEN are the most mentioned tickers in articles about PETQ.
Latest PETQ News From Around the Web
Below are the latest news stories about PetIQ Inc that investors may wish to consider to help them evaluate PETQ as an investment opportunity.
Philips (PHG) is recalling some Bi-Level PAP, CPAP, and mechanical ventilator devices in the United States due to health risks.
QIAGEN's (QGEN) alliance will facilitate co-development of KRAS companion diagnostic with Mirati's, adagrasib, a selective and potent oral inhibitor of KRAS G12C.
EAGLE, Idaho, May 26, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team will participate in two upcoming virtual investor conferences.
An investigation on behalf of investors in PetIQ, Inc. (NASDAQ:PETQ) shares over potential wrongdoing at PetIQ, Inc. was announced and NASDAQ:PETQ stockholders should contact the Shareholders Foundation. San Diego, CA -- ( SBWIRE ) -- 05/12/2021 -- An investigation on behalf of current long-term investors in shares of PetIQ, Inc. (NASDAQ: PETQ) was announced over potential breaches of fiduciary duties by certain officers and directors at PetIQ, Inc. Investors who purchased shares of PetIQ, Inc. (NASDAQ: PETQ) and currently hold any of those NASDAQ: PETQ shares have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain PetIQ, Inc. directors breached their fiduc...
Equities research analysts expect that PetIQ, Inc. (NASDAQ:PETQ) will post $308.93 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for PetIQs earnings. The lowest sales estimate is $296.30 million and the highest is $328.73 million. PetIQ reported sales of $266.98 million in the same quarter last year, 
Equities research analysts expect that PetIQ, Inc. (NASDAQ:PETQ) will announce $0.74 earnings per share (EPS) for the current quarter, according to Zacks. Five analysts have made estimates for PetIQs earnings, with the lowest EPS estimate coming in at $0.47 and the highest estimate coming in at $0.94. PetIQ posted earnings per share of $0.70 during 
Oppenheimer Stick to Their Buy Rating for Petiq Inc
PetIQ (PETQ) delivered earnings and revenue surprises of 200.00% and 20.51%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
First Quarter 2021 Net Sales Increase 36.2% Year-Over-Year to $254.3 MillionEAGLE, Idaho, May 05, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months ended March 31, 2021. Cord Christensen, PetIQ’s Chairman & CEO commented, “Our record start to the year demonstrates the strength and momentum across our pet health and wellness business. The first quarter financial results reflect continued robust growth from both our manufactured and distributed pet products across all sales channels and we experienced an important inflection point in our Services business as the headwinds from the pandemic have started to abate. We remain excited about the future trajectory of...
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / PetIQ, Inc. (NASDAQ:PETQ) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.